Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
1076.3500
47.85
(
4.65
%)
NSE
Feb 25, 2026
15:31 PM
107.93% Gain from 52W Low
Volume:
2.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
29 Jul 2024
1076.35
4.65%
Laurus Labs Limited
Neutral:
Laurus Labs Ltd.
by
Keynote Capitals Ltd
Target: 456
Target
Keynote Capitals Ltd
Quarterly Update Q1FY25
Number of FII/FPI investors increased from 340 to 421 in Dec 2025 qtr.
More from Laurus Labs Ltd.
Recommended
Market closes higher, supported by a rebound in IT stocks & positive global cues
Trendlyne Marketwatch |
25 Feb 2026, 03:57PM
Five stocks to buy from analysts this week - February 24, 2026
The Baseline |
24 Feb 2026, 06:01PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020